Home ›
Trademark Categories ›
Pharmaceuticals ›
2013 ›
SE ›
SELE03
Trademark search for:
SELE03
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2014-09-02 — Application filed
2014-09-05 — Application filed
2014-09-12 — Application filed
2014-09-13 — Notice of pseudo mark e-mailed
2014-12-14 — Assigned to examiner
2014-12-15 — Approved for pub - principal register
2015-01-07 — Notification of notice of publication e-mailed
2015-01-27 — Published for opposition
2015-01-27 — Official gazette publication confirmation e-mailed
2015-03-24 — Noa e-mailed - sou required from applicant
2015-09-24 — Sou teas extension received
2015-09-24 — Sou extension 1 filed
2015-09-24 — Sou extension 1 granted
2015-09-26 — Notice of approval of extension request e-mailed
2016-03-24 — Sou teas extension received
2016-03-24 — Sou extension 2 filed
2016-04-28 — Case assigned to intent to use paralegal
2016-05-03 — Sou extension 2 granted
2016-05-04 — Notice of approval of extension request e-mailed
2016-09-23 — Sou teas extension received
2016-09-23 — Sou extension 3 filed
2016-10-22 — Sou extension 3 granted
2016-10-25 — Notice of approval of extension request e-mailed
2017-03-24 — Sou teas extension received
2017-03-24 — Sou extension 4 granted
2017-03-24 — Sou extension 4 filed
2017-03-28 — Notice of approval of extension request e-mailed
2017-09-25 — Sou extension 5 filed
2017-10-30 — Application abandoned
2017-10-30 — Application abandoned
2017-12-29 — Sou extension received with teas petition
2017-12-29 — Notice of revival - e-mailed
2017-12-29 — Petition to revive-granted
2017-12-29 — Teas petition to revive received
2018-01-22 — Case assigned to intent to use paralegal
2018-01-24 — Sou extension 5 granted
2018-01-25 — Notice of approval of extension request e-mailed
2018-04-30 — Application abandoned
2018-04-30 — Application abandoned
2018-04-30 — Final status recorded
Owner Information
NovelMed Therapeutics, Inc.
NovelMed Therapeutics, Inc.
Correspondent
RICHARD A. SUTKUS TAROLLI, SUNDHEIM, COVELL & TUMMINO LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
